Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Rivière

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2017
Chimeric Antigen Receptors: A Cell and Gene Therapy PerspectiveIsabelle Rivière, Michel Sadelain
Molecular Therapy Oncolytics|June 28, 2016
Clinical manufacturing of CAR T cells: foundation of a promising therapyXiuyan Wang, Isabelle Rivière
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Sturm und drang over suicidal lymphocytesMichel Sadelain, Isabelle Rivière
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2017
Perspectives on Manufacturing of High-Quality Cell TherapiesIsabelle Rivière, Krishnendu Roy
Molecular Therapy. Methods & Clinical Development|May 9, 2017
Genetic Engineering and Manufacturing of Hematopoietic Stem CellsXiuyan Wang, Isabelle Rivière
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trialsTulin Budak-Alpdogan, Isabelle Rivière
Nature|May 26, 2017
Therapeutic T cell engineeringMichel Sadelain, Isabelle Rivière, Stanley Riddell
Hemoglobin|December 17, 2009
Gene therapy for homozygous beta-thalassemia. Is it a reality?Farid Boulad, Isabelle Rivière, Michel Sadelain
Cell Stem Cell|April 7, 2015
New cell sources for T cell engineering and adoptive immunotherapyMaria Themeli, Isabelle Rivière, Michel Sadelain
Cancer Discovery|April 4, 2013
The basic principles of chimeric antigen receptor designMichel Sadelain, Renier Brentjens, Isabelle Rivière
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2017
Chimeric Antigen Receptors: A Cell and Gene Therapy PerspectiveIsabelle Rivière, Michel Sadelain
Molecular Therapy Oncolytics|June 28, 2016
Clinical manufacturing of CAR T cells: foundation of a promising therapyXiuyan Wang, Isabelle Rivière
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Sturm und drang over suicidal lymphocytesMichel Sadelain, Isabelle Rivière
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2017
Perspectives on Manufacturing of High-Quality Cell TherapiesIsabelle Rivière, Krishnendu Roy
Molecular Therapy. Methods & Clinical Development|May 9, 2017
Genetic Engineering and Manufacturing of Hematopoietic Stem CellsXiuyan Wang, Isabelle Rivière
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trialsTulin Budak-Alpdogan, Isabelle Rivière
Nature|May 26, 2017
Therapeutic T cell engineeringMichel Sadelain, Isabelle Rivière, Stanley Riddell
Hemoglobin|December 17, 2009
Gene therapy for homozygous beta-thalassemia. Is it a reality?Farid Boulad, Isabelle Rivière, Michel Sadelain
Cell Stem Cell|April 7, 2015
New cell sources for T cell engineering and adoptive immunotherapyMaria Themeli, Isabelle Rivière, Michel Sadelain
Cancer Discovery|April 4, 2013
The basic principles of chimeric antigen receptor designMichel Sadelain, Renier Brentjens, Isabelle Rivière
Pageof 7